Shineco (SISI) announced that InfiniClone, Shineco’s majority-owned subsidiary in which the Company acquired a 51% equity interest on April 25, 2025, has officially launched its Southeast Asian market expansion strategy as it has reached a strategic distribution agreement with Total World Marketing, TWM, pursuant to which TWM will be responsible for the promotion and sale of InfiniClone’s molecular detection kits and InfiniClone’s Purelix series health products in the Southeast Asian market. Shineco believes that this marks a key step in its globalization strategy to develop robust market positioning in the healthcare products and services sector.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SISI:
